Obesity and kidney cancer risk in men - A meta-analysis (1992-2008)

Asian Pacific Journal of Cancer Prevention

Volumn 10, Issue 2, 2009, Pages 279-286

  Ildaphonse, Grata ^a   George, Preethi Sara ^a   Mathew, Aleyamma ^a  

^a REGIONAL CANCER CENTRE   (India)

Author keywords

Kidney cancer risk; Meta analysis; Obesity

Indexed keywords

EID: 67651160840     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Adams KF, Leitzmann MF, Albanes D, et al (2008). Body size and renal cell cancer incidence in a large US cohort study. Am J Epidemiol, 168, 268-77.
2. Abubakari AR, Lauder W, Agyemang C, et al (2008). Prevalence and time trends in obesity among adult West African populations: a meta-analysis. Obes Rev, 9, 297-311.
3. Ahacic K, Kennison R, Thorslund M (2008). Trends in smoking in Sweden from 1968 to 2002: age, period, and cohort. Prev Med, 46, 558-64.
4. Benhamou S, Lenfant MH, Ory-paolettic, Flamant R (1993). Risk factors for renal cell carcinoma in a French case control study. Int J Cancer, 55, 32-6.
5. Benichou J, Chow W-H, Mclaughlin JK, Mandel JS, Fraumeni JF Jr (1998). Population attributable risk of renal cell cancer in Minnesota. Am J Epidemiol, 148, 424-30.
6. Bergstrom A, Hsieh CC, Lindblad P, et al (2001). Obesity and renal cell carcinoma, a quantitative review. Br J Cancer, 85, 984-90.
7. Bjorge T, Tretli S, Engeland A (2004). Relation of height and body mass index to renal cell carcinoma in two million Norwegian men and women. Am J Epidemiol, 160, 1168-76.
8. Calle EE, Rodriguez C, Thurmond KW, Thun MJ (2003). Overweight, obesity and mortality from cancer in a prospectively studied cohort of US adults. New Eng J Med, 348, 1625-38.
9. Chen Y, Rennie DC, Dosman JA (2008). Changing prevalence of obesity in a rural community between 1977 and 2003: A multiple cross-sectional study. Public Health, (in press).
10. Chiu BC-H, Gapstur SM, Chow W-H, et al (2006). Body mass index, physical activity, and risk of renal cell carcinoma. Int J Obesity, 30, 940-7.
11. Chow WH, Devesa SS, Warren JL, Frumeni JF Jr (1999). Rising incidence of renal cell cancer in the United States. JAMA, 281, 1628-31.
12. Chow WH, Gridley G, Frumeni JF Jr, Jasiholm B (2000). Obesity, hypertension and the risk of kidney cancer in men. N Engl J Med, 343, 1305-11.
13. Chow WH, McLaughlin JK, Mandel JS, et al (1996). Obesity and risk of renal cell cancer. Cancer Epidemiol Biomarkers Prevent, 5, 17-21.
14. Curado MP, Edwards, B, Shin HR, et al (eds) (2007). Cancer Incidence in Five Continents, Vol. IX, IARC Scientific Publications No. 160, Lyon, IARC.
15. Duval S, Jacobs DR Jr, Barber C, et al (2008). Trends in cigarette smoking: the Minnesota Heart Survey, 1980-1982 through 2000-2002. Nicotine Tob Res, 10, 827-32.
16. Edwards R, Bowler T, Atkinson J, Wilson N (2008). Low and declining cigarette-smoking rates among doctors and nurses: 2006 New Zealand Census data. N Z Med J, 121, 43-51.
17. Falebita OA, Mancini S, Kiely E, Comber H (2008). Rising incidence of renal cell carcinoma in Ireland. Int Urol Nephrol, (in press).
18. Ferlay J, Bary F, Pisani P, Parkin DM (2004). Globocan 2002: Cancer incidence, mortality and prevalence Worldwide. International Agency for research on Cancer. Cancer Base no.5 version 2.0. IARC press, Lyon.
19. Flaherty KT, Fuchs CS, Colditz GA, et al (2005). A prospective study of body mass index, hypertension and smoking and the risk of renal cell carcinoma (United States). Cancer Causes Control, 16, 1099-106.
20. Frystyk J, Vestbo E, Skjaerbaek C, Mogensen CE, Orskov H (1995). Free insulin-like growth factors in human obesity. Metabolism, 44, 37-44.
21. Greenland S (1987). Quantitative methods in the review of epidemiologic literature. Epidemiol Rev, 9, 1-30.
22. Greenland S, Longnecker MP (1992). Methods for trend estimation from summarized dose-response data, with application to meta-analysis. Am J Epidemiol, 135, 1301-9.
23. Hall JE, Louis K (1994). Dahl Memorial Lecture -Renal and cardiovascular mechanisms of hypertension in obesity. Hypertension, 23, 381-94.
24. Heath CW Jr, Lally CA, Calle EE, McLaughlin JK, Thun MJ (1997). Hypertension, diuretics and antihypertensive medication as possible risk factors for renal cell cancer. Am J Epidemiol, 145, 607-13.
25. Hiatt RA, Tolan K, Quesenberry CP Jr (1994). Renal cell carcinoma and thiazide use: a historical, case-control study (California, USA). Cancer Causes Control, 5, 319-25.
26. Hill AB (1965). The environment and disease: association or causation? Proc R Soc Med, 58, 295-300.
27. Hu J, Mao Y, White K,, and The Canadian Cancer Registries Epidemiology Research Group (2003). Overweight and obesity in adults and risk of renal carcinoma in Canada. Soz-Preventiv Med, 48, 178-85.
28. Il'yasova D, Hertz-Picciotto I, Peters U et al (2005). Choice of exposure scores for categorical regression in meta-analysis: a case study of a common problem. Cancer Causes Control, 16, 383-8.
29. Kellerer M, von Eye Corleta H, Muhlhofer A, et al (1995). Insulin-an insulin-like growth-factor-I receptor tyrosine-kinase activities in human renal carcinoma. Int J Cancer, 62, 501-7.
30. Levi F, Ferlay J, Galeone C, et al (2008). The changing pattern of kidney cancer incidence and mortality in Europe. BJU Int, 101, 949-58.
31. Lilja M, Eliasson M, Stegmayr B, Olsson T, Söderberg S (2008). Trends in obesity and its distribution: Data from the Northern Sweden MONICA Survey, 1986-2004. Obesity, (in press).
32. Lindblad P, Wolk A, Bergstrom R, Person I, Adami H (1994). The role of obesity and weight fluctuations in the etiology of renal cell carcinoma: A population-based case-control study. Cancer Epidemiol Biomarkers Prevent, 3, 631-9.
33. Lipworth L, Tarone RE, McLaughlin JK (2006). The epidemiology of renal cell carcinoma. J Urol, 176, 2353-8.
34. Lou J, Margolis KL, Adami HO, et al for the women's health initiative investigators (2007). Body size, weight cycling and risk of renal cell carcinoma among postmenopausal women: The women's health initiative (United States). Am J Epidemiol, 166, 752-9.
35. Lukanova A, Bjor O, Kaaks R, et al (2006). Body mass index and cancer: results from the Northern Sweden Health and Disease cohort. Int J Cancer, 118, 458-66.
36. Kriger N, Marret LD, Dodds L, Hilditch S, Darlington GA (1993). Risk factors for renal cell carcinoma: results of a population based case-control study. Cancer Causes Control, 4, 101-10.
37. Maso LD, Zucchetto A, Tavani A, et al (2007). Renal cell cancer and body size at different ages: an Italian Multicenter casecontrol study. Am J Epidemiol, 166, 582-91.
38. McLaughlin JK, Gao YT, Gao RN, et al (1992). Risk factors for renal-cell cancer in Shanghai, China. Int J Cancer, 52, 562-5.
39. Mclaughlin JK and Lipworth L (2000). Epidemiologic aspects of renal cell cancer. Semin Oncol, 27, 115-23.
40. Mathew A, Devesa SS, Fraumeni JF Jr, Chow WH (2002). Global increases in kidney cancer incidence, 1973-1992. Eur J Cancer Prev, 11, 171-8.
41. Matsushita Y, Takahashi Y, Mizoue T, et al (2008). Overweight and obesity trends among Japanese adults: a 10-year follow-up of the JPHC Study. Int J Obes, (in press).
42. McCredie M, Stewart JH (1992). Risk factors for kidney cancer in New South Wales, Australia.II. Urologic diseases, hypertension, obesity, and hormonal factors. Cancer Causes Control, 3, 323-31.
43. Mellengaard A, Engholm G, McLaughlin JK, Olsen JH (1994). Risk factors for renal cell carcinoma in Denmark. III. Role of weight, physical activity and respective factors. Int J Cancer, 56, 66-71.
44. Mellengaard A, Lindblad P, Schlehofer B, et al (1995). International renal-cell cancer study. III. Role of weight, height, physical activity, and use of amphetamines. Int J Cancer, 60, 350-4.
45. Møller H, Mellemgaard A, Lindvig K, Olsen JH (1994). Obesity and cancer risk: A Danish record-linkage study. Eur J Cancer, 30, 344-50.
46. Monteiro CA, Cavalcante TM, Moura EC, Claro RM, Szwarcwald CL (2007). Population-based evidence of a strong decline in the prevalence of smokers in Brazil (1989-2003). Bull World Health Organ, 85, 527-34.
47. Mosterd A, D'Agostino RB, Silbershatz H, et al (1999). Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. N Engl J Med, 340, 1221-7.
48. Moyad MA (2001). Obesity, interrelated mechanisms, and exposures and kidney cancer. Semin Urol Oncol, 19, 270-9.
49. Oh SW, Yoon YS, Shin S-A (2005). Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study. J Clin Oncol, 23, 4742-54.
50. Pan SY, DesMeules M, Morrison H, Wen SW: The Canadian Cancer Registries Epidemiology Research Group (2006). Obesity, high-energy intake, lack of physical activity and the risk of kidney cancer. Cancer Epidemiol Biomarkers Prev, 15, 2453-60.
51. Pan SY, Johnson KC, Ugnat AM, Wen SW, Mao Y (2004). The Canadian Cancer Registries Epidemiology Research Group. Association of obesity and cancer risk in Canada. Am J Epidemiol, 154, 259-68.
52. Pérez-Farinós N, López-Abente G, Pastor-Barriuso R (2006). Time trend and age-period-cohort effect on kidney cancer mortality in Europe, 1981-2000. BMC Public Health, 6, 119.
53. Petiti DB (2000). Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis. Oxford University Press, Oxford.
54. Pischon T, Lahmann PH, Boeing H et al (2006). Body size and risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer, 118, 728-38.
55. Ribstein J, du Cailar G and Mimran A (1995). Combined renal effects of overweight and hypertension. Hypertension, 26, 610-5.
56. Rothman K, Greenland S (1998). Precision and validity in epidemiologic studies. In: Modern Epidemiology, Rothman K, Greenland S (ed). Lippincott-Raven: Philadelphia. 115-134.
57. Samanic C, Chow W-H, Gridley G, Jarvholm B, Fraumeni JF Jr. (2006) Relationation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control, 17, 901-9.
58. Schlehofer B, Pommer W, Mellemgaard A, et al (1996). International renal cell cancer study. VI, the role of medical and family history. Int J Cancer, 66, 723-26.
59. Seber GAF, Wild CJ (1989). Nonlinear Regression. New York: John Wiley and Sons. Inc Publishers.
60. Setiawan VW, Stram DO, Nomura AMY, Kolonel LN, Henderson BE (2007). Risk factors for renal cell cancer: The multiethnic cohort. Am J Epidemiol, 166, 932-40.
61. Shapiro JA, Williams MA, Weiss NS (1999). Body mass index and risk of renal cell carcinoma. Epidemiology 10:188-191.
62. Spyridopoulos TN, Petridou ET, Skalkidou A, et al (2007). Low adiponectin levels are associated with renal cell carcinoma: case-control study. Int J Cancer, 120, 1573-8.
63. Stadler W, Vogdzang NJ (1993). Human renal cancer carcinogenesis: a review of recent advances. Ann Oncol, 4, 451-62.
64. Van Dijk B A, Schouten LJ, Lamberts AL, et al (2004). Relation of height, body mass, energy intake, and physical activity to risk of renal cell carcinoma: Results from the Netherlands Cohort Study. Am J Epidemiol, 160, 1159-67.
65. Wildman RP, Gu D, Muntner P, Wu X, et al (2008). Trends in overweight and obesity in Chinese adults: between 1991 and 1999-2000. Obesity, 16, 1448-53.
66. Yuan JM, Castelao JE, Dominguez MG, Ross RK, Yu MC (1998). Hypertension, obesity and their medications in relation to renal cell carcinoma. Br J Cancer, 77, 1508-13.